1. Signaling Pathways
  2. GPCR/G Protein
    Immunology/Inflammation
  3. CXCR
  4. CXCR Inhibitors

CXCR Inhibitors

CXCR

CXCR1

CXCR2

CXCR3

CXCR4

CXCR7

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

CXCR Inhibitors, Agonists, Antagonists & Modulators
Product Name CXCR CXCR1 CXCR2 CXCR3 CXCR4 CXCR7 Purity
Plerixafor        
125I-CXCL12-CXCR4, IC50: 44 nM
  >98.0%
AMG 487      
125I-IP10-CXCR3, IC50: 8 nM
125I-ITAC-CXCR3, IC50: 8.2 nM
    99.65%
SB225002    
125I-IL-8-CXCR2, IC50: 22 nM (in CHO cell membrane)
      99.78%
AZD-5069    
125I-IL-8-CXCR2
      99.92%
Navarixin  
Cynomolgus CXCR1, Kd: 41 nM
125I-CXCL8-CXCR1, IC50: 43 nM
Mouse CXCR2, Kd: 0.2 nM
Rat CXCR2, Kd: 0.2 nM
Cynomolgus CXCR2, Kd: 0.08 nM
125I-CXCL8-CXCR2, IC50: 0.97 nM
      98.62%
NUCC-390 dihydrochloride        
CXCR4
  99.59%
Elubrixin tosylate    
CXCR2
      99.74%
PS372424 hydrochloride      
Human CXCR3
    >98.0%
Plerixafor octahydrochloride        
125I-CXCL12-CXCR4, IC50: 44 nM
  >98.0%
Reparixin  
CXCR1wt, IC50: 5.6 nM (in L1.2 cells)
CXCR1Ile43Val, IC50: 80 nM (in L1.2 cells)
CXCR1, IC50: 1 nM (in cells)
CXCR2, IC50: ∼100 nM (in cells)
      99.98%
AZD8797    
125I-IL-8-CXCR2, Ki: 2800 nM (in HEK293S cells)
      98.65%
Mavorixafor trihydrochloride        
125I-SDF-CXCR4, IC50: 13 nM
  99.14%
Motixafortide        
CXCR4, IC50: ~1 nM
  98.27%
LY2510924        
125I-SDF-1α-CXCR4, IC50: 79.7 pM
125I-SDF-1α-CXCR4, Ki: 49.5 pM
  99.91%
Reparixin L-lysine salt  
CXCR1wt, IC50: 5.6 nM (in L1.2 cells)
CXCR1Ile43Val, IC50: 80 nM (in L1.2 cells)
CXCR1, IC50: 1 nM (in cells)
CXCR2, IC50: ∼100 nM (in cells)
      99.97%
Baohuoside I        
CXCR4
  99.70%
SCH 546738      
Human CXCR3, Ki: 0.4 nM
    99.23%
TAK-779      
mCXCR3, IC50: 369 nM (in PBMCs)
    99.73%
IT1t dihydrochloride        
CXCL12/CXCR4, IC50: 2.1 nM
  99.97%
Danirixin    
CXCL8-CXCR2, IC50: 12.5 nM
      98.21%
SX-682  
CXCR1
CXCR2
      98.52%
Burixafor hydrobromide        
CXCR4
  >98.0%
MSX-122        
CXCR4/CXCL12, IC50: ~10 nM
  98.29%
USL311        
CXCR4
  99.97%
AMD 3465 hexahydrobromide        
12G5 mAb-CXCR4, IC50: 0.75 nM (in SupT1 cells)
CXCL12AF647-CXCR4, IC50: 18 nM (in SupT1 cells)
  98.79%
WZ811        
CXCR4, EC50: 0.3 nM
  >99.0%
NBI-74330      
[125I]CXCL10-CXCR3, Ki: 1.5 nM (in CXCR3-CHO cell membranes)
[125I]CXCL11-CXCR3, Ki: 3.2 nM (in CXCR3-CHO cell membranes)
    99.23%
FC131 TFA        
125I-SDF-1-CXCR4, IC50: 4.5 nM
  99.87%
SCH 563705  
CXCR1, Ki: 3 nM
CXCR1, IC50: 7.3 nM
CXCR2, Ki: 1 nM
CXCR2, IC50: 1.3 nM
Mouse CXCR2, IC50: 5.2 nM
      95.34%
Balixafortide TFA        
CXCR4, IC50: <10 nM
  98.19%
CXCR2-IN-1    
CXCR2, pIC50: 9.3
      99.26%
SRT3109    
CXCR2, pIC50: 8.2
      99.82%
SRT3190    
CXCR2
      99.32%
CXCR7 modulator 1          
CXCR7, Ki: 9 nM
99.67%
ALX 40-4C Trifluoroacetate        
SDF-1-CXCR4, Ki: 1 μM
  98.15%
ALX 40-4C        
SDF-1-CXCR4, Ki: 1 μM
 
NUCC-390        
CXCR4
 
SB-265610    
CXCR2
      >99.0%
PS372424      
Human CXCR3
   
Mavorixafor        
125I-SDF-CXCR4, IC50: 13 nM
 
AMG 487 (S-enantiomer)      
CXCR3
    98.92%
Nicotinamide N-oxide    
CXCR2
      99.93%
AMD 3465        
12G5 mAb-CXCR4, IC50: 0.75 nM (in SupT1 cells)
CXCL12AF647-CXCR4, IC50: 18 nM (in SupT1 cells)
 
UNBS5162
CXCL
          99.75%
CXCR7 modulator 2          
CXCR7, Ki: 13 nM
>98.0%
MSX-127        
CXCR4
 
CTCE-9908 TFA        
CXCR4
 
TC14012 TFA        
CXCR4, IC50: 19.3 nM (antagonist site)
CXCR7, EC50: 350 nM (agonist site)
Corydalmine    
CXCR2
     
MSX-130        
CXCR4
 
VUF11207 fumarate          
CXCR7, pKi: 8.1
98.50%